Literature DB >> 7036357

Improvement of diabetic peripheral neuropathy with the portable insulin infusion pump.

A Tolaymat, J L Roque, L S Russo.   

Abstract

A 16-year-old girl with insulin dependent (Type I) diabetes since age 9 and painful sensory neuropathy for two months was treated with a portable insulin infusion pump, allowing strict control of hyperglycemia. Within 28 days the distal motor latency in all nerves tested had improved and painful incapacitating dysesthesias disappeared. The findings suggest that strict control of hyperglycemia with a portable insulin infusion pump can successfully reverse the changes of recent onset diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036357     DOI: 10.1097/00007611-198202000-00017

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.

Authors:  F J Service; R A Rizza; J R Daube; P C O'Brien; P J Dyck
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

Review 2.  Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.

Authors:  D A Greene
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion.

Authors:  F W Bertelsmann; J J Heimans; J C Van Rooy; H F Dankmeijer; S L Visser; E A Van der Veen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

4.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.